Abiopharma

Director Le-Quoc Alexis 🟡 adjusted position in 6.3M shares (6 derivative) of Datadog, Inc. (DDOG) at $150.00 ($8.1M) Transaction Date: May 04, 2026 | Filing ID: 000126

Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate Progress

Onterris Reports First Quarter Results and Reiterates Full-Year 2026 Guidance

Blue Bird Reports Fiscal 2026 Second Quarter Results

Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results

Central Garden & Pet Announces Record Q2 Fiscal 2026 Financial Results

(99% Neutral) AXCELIS TECHNOLOGIES INC (ACLS) Announces Regulatory Update

Galapagos Reports First Quarter 2026 Financial Results and Provides Business Update

EPSTEIN ROBERT S 🟢 acquired 50.0K shares (1 derivative) of FATE THERAPEUTICS INC (FATE) at $1.69 Transaction Date: May 05, 2026 | Filing ID: 208899

(99% Neutral) KEMPER CORP (KMPB) Provides Business Update

📋 Brown Claude Leonard (Officer) plans to sell 61K shares of PINTEREST, INC. (at $20.87 each, total $1.3M) Filed: May 06, 2026 | ID: 000445

New Form SCHEDULE 13G/A - CapsoVision, Inc <b>Filed:</b> 2026-05-06 <b>AccNo:</b> 0001009165-26-000003 <b>Size:</b> 18 KB

(85% Positive) LEXICON PHARMACEUTICALS, INC. (LXRX) Announces Business Combination

Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026

argenx Announces Results of Annual General Meeting and Board ofDirectors’ Appointment of Karen Massey as Chief Executive Officer